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Endothelial nitric oxide synthase (eNOS) contains a motif similar to recognition sequences in known
MAPK binding partners. In optical biosensing experiments, eNOS bound p38 and ERK with 100 nM
afﬁnity and complex kinetics. Binding is diffusion-limited (kon  .15  106 M1 s1). Neuronal NOS
also bound p38 but exhibited much slower and weaker binding. p38-eNOS binding was inhibited
by calmodulin. Evidence for a ternary complex was found when eNOS bound p38 was exposed to
CaM, increasing the apparent dissociation rate. These observations strongly suggest a direct role
for MAPK in regulation of NOS with implications for signaling pathways including angiogenesis
and control of vascular tone.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Kinases of the MAPK family are central nodes in stress activated
signaling networks regulating gene expression in response to envi-
ronmental changes, inﬂammatory cytokines, and other signals.
ERK1/2, p38 and eNOS-generated NO are involved in processes
such as angiogenesis, ischemia-reperfusion and insulin response
[1–10]. Experimental evidence indicates that ERK1/2 phosphory-
lates eNOS in a bradykinin-sensitive ERK1/2-AKT-eNOS-Raf-1 com-
plex in BAECs [11]. p38 is stimulated by upstream kinases via
several pathways and activates a broad spectrum of downstream
kinases, including MAPKAP kinases 2 and 3 and numerous tran-
scription factors such as ATF1/2 and MEF2A [3,12]. Many binding
partners for ERK, p38 and JNK contain a basic recognition site
within the D-site (Fig. 1) that facilitates interaction between MAP
kinases and other signaling components [1–4,12].
The canonical binding site for recognition by MAP kinases is
KKRxxxLxI, but considerable variation from this motif has been
postulated to facilitate recognition by a helix and neighboringal Societies. Published by Elsevier
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no).regions on MAPKs that bear an array of acidic and hydrophobic
residues. Among several alternatives, Enslena et al. proposed that
(R/K)2-(x)2–6-(L/I)  (L/I) is a more general motif [13]. Sharrocks
et al. presented an even more general scheme for recognition of
substrates by MAP kinases involving a multibasic region, an LxL re-
gion, and ﬂanking C and N terminal hydrophobic residues; at least
two of these four determinants were present in all sequences con-
sidered [14]. More recently a series of peptides based on putative
recognition sites has been used to probe the speciﬁcity of a variety
of MAP kinases. Variations within the D site contribute to, but do
not completely account for, differential binding of related sub-
strates to JNK, ERK and p38 type kinases, all of which recognize
these motifs [4].
The endothelial nitric oxide synthase (eNOS) is an important
signal generator involved in the control of vascular tone, insulin
secretion, and angiogenesis [6–10]. The primary controller of eNOS
is displacement of an autoinhibitory element by Ca+2/CaM
(calcium/calmodulin) [15], but eNOS is also regulated by several
kinases acting at different sites to activate or inhibit NO production
[16–18]. eNOS regulation also involves targeting to different
compartments via myristolation, palmitoylation and protein–pro-
tein interactions. Some of the activating phosphorylation sites
are within the autoinhibitory element (S617 and S633 in bovine
eNOS), and are phosphorylated by PKA and AKT.
The autoinhibitory element contains a conserved region com-
mon to CaM regulated NOS enzymes; this includes the phosphory-
lation sites and a helical region that forms hydrogen bonds with
the FMN binding domain and with the two domain dehydrogenase
unit with which it is associated in the available crystal structureB.V. Open access under CC BY-NC-ND license.
Fig. 1. Alignment of the pentabasic sequence (bold) in eNOS and the aligned region
in nNOS and with the D sites of MK2-B, MK3, and MKK6. The classic D site sequence
is characterized by (K/R2-3- X1-6-u-X-u) (Ref. [4]), is bolded and underlined in the
MKK6 sequence. MK2-B and MK3 lack the hydrophobic portion of the D site, similar
to eNOS. All sequences are human unless otherwise designated; the sequence
corresponding to the recognition region is essentially invariant within each group of
mammalian kinase and NOS orthologs.
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conserved at the protein level because of local frame shifts which
generated a unique pentabasic sequence in mammalian eNOS. As
shown in Fig. 1, the corresponding region of nNOS contains only
two basic residues, although there are other basic residues, notably
a triplet nearby in the canonical calmodulin-binding motif.
Biosensor experiments provide a powerful and versatile probe
of protein–protein interactions, allowing veriﬁcation of predicted
binding and quantitative description of afﬁnity and kinetics of
binding and release. Our recent work utilized optical biosensing
to elucidate calcium dependent changes to the rates and afﬁnity
of calmodulin binding to NOS [20]. Here we show that very com-
pact versions of the D site can be detected and bind with high afﬁn-
ity to MAP kinases such as p38 and ERK1/2. In particular, ERK1/2
binds eNOS but not nNOS and p38 strongly binds to endothelial ni-
tric oxide synthase, but makes a much weaker complex with the
neuronal isoform, consistent with the recognition of a pentabasic
sequence in eNOS by p38. p38-eNOS binding is inhibited and
release stimulated by CaM, suggesting a weak ternary complex.
Inhibition of eNOS by p38 is consistent with partial competition
with CaM.
2. Materials and methods
NOSs were expressed and puriﬁed as described [21–23]. Heme
and ﬂavin content were estimated spectrophotometrically, and
activity assayed by following NADPH consumption at 340 nm
[22,23]. Assays of eNOS NO synthase activity and cytochrome c
reduction were performed essentially as described [24,25]. The
concentration of CaM was reduced to 0.6 lM because of potential
competition between CaM and p38. Phosphorylated His-p38 was
expressed as described previously [26] and puriﬁed using Talon™
resin as directed by the manufacturer. ERK-2 was purchased from
PROSPEC (New Jersey). All biolayer interferometry [27] measure-
ments were made on a ForteBio (Menlo Park, CA) Octet QK biosen-
sor using streptavidin sensors. Assays were performed in 200 lL
volumes at 25 C. p38 and ERK were biotinylated as previously
described [20]. Biotinylated kinases were loaded onto sensors for
600 s. After establishing baseline response, kinases were exposed
to analyte eNOS or nNOS at a range of concentrations. Baseline,
association and dissociation phases were all performed in NOS buf-
fer (10 mM phosphate, pH 7.5, 100 mM NaCl, 10% glycerol, 0.005%
surfactant P-20, 10 lM CaCl2). Association and dissociation were
monitored as nm shift. Nonspeciﬁc binding of analytes to sensors
without ligand was negligible and so was not subtracted.
Binding and release of analyte was simulated using standard
kinetics approaches [20]. A single ﬁrst order model generated
acceptable simulations for only the ﬁrst 30 s of binding, but good
quality ﬁts were obtained using two components with eithersequential (A+BMCMD) or parallel (A+BMC; D+BME) models.
Sequential binding was modeled at each analyte concentration
with pseudo ﬁrst order rate constants k1 and k2 for the forward
and reverse reactions of the initial step and k3 and k4 for the for-
ward and reverse rate constants of the second step. Binding curves
were calculated numerically and forward and reverse rate con-
stants extracted by simulation at all analyte concentrations exam-
ined. Parallel model simulation of the forward reactions was done
using summed exponentials; the observed pseudo ﬁrst order rate
constant kobs is then the sum of the forward and reverse rates. In
both cases the second order rate constant is the product of analyte
concentration and pseudo ﬁrst order forward rate constant k1.3. Results
3.1. eNOS binds to p38
In Fig. 2A trace a shows binding of eNOS to tethered p38. Bind-
ing is rapid; an initial component accounts for about 2/3 of the sig-
nal and has a half time of 10 s. A second, slower component
appears to represent changes in protein conformation on the sen-
sor. After 300 s, the sensor was immersed in buffer only; dissocia-
tion of about 25% of the rapid phase binding was observed,
consistent with conversion of the remaining complex to a slowly
dissociating form in the second phase of association. After dissoci-
ation in buffer, the sensor was moved to buffer containing CaM.
Dissociation was still incomplete, but signiﬁcantly more rapid
and extensive. We regard the rapid phase of association as repre-
sentative of potentially physiologically relevant events; very slow
conformational changes of protein associated with the sensor sur-
face likely represent partial unfolding or aggregation.
Trace b shows the binding of nNOS to p38. The low amplitude of
the signal compared to eNOS indicates that binding is an order of
magnitude weaker, and binding is 30-fold slower. It is important
to understand that in trace a eNOS is present at saturating concen-
trations, while the same concentration of nNOS is below the Kd;
similar binding of eNOS can be obtained at concentrations about
thirty fold lower (see titration in Fig. 2). Weak association of nNOS
to p38 may be through basic residues in the AI or the CaM binding
region, or may represent a different mode of interaction.
Mutants of eNOS have been previously studied in which the
control elements have been deleted [28]. Binding of an deletion
mutant in which the autoinhibitory element has been removed
to p38 is comparable to the binding of nNOS, but since the non-
speciﬁc binding of the eNOS mutant is somewhat greater than that
of wild type enzymes, it is not possible to draw more detailed
conclusions about weak secondary binding sites at this time. The
results are consistent with the behavior of nNOS.
Trace c shows p38 immersed in eNOS as in trace a except that
excess Ca+2/CaM was present during association. CaM abolishes
binding, suggesting that binding sites overlap, consistent with rec-
ognition of the pentabasic motif. p38-eNOS interaction can also be
observed with eNOS as ligand and p38 as free analyte (data not
shown). The signal is much smaller; this is expected because eNOS
is a large protein (dimer molecular weight 260 kDa) and p38 is
much smaller (MW  41 kDa). Inhibition by CaM was also ob-
served. Reversibility of ligand and analyte demonstrates that the
interaction is not an artifact of immobilization.
Fig. 2B shows concentration dependence of eNOS binding to
p38. Simulation with two components produces good ﬁts; a
sequential ﬁt is shown, but good ﬁts can also be obtained with
two parallel components. The rapid association phase, most likely
to be physiologically relevant, is insensitive to choice of model.
Note that the magnitude and rate of eNOS binding that most
Fig. 2. (A) Sensorgrams of eNOS and nNOS binding to p38. Immobilized p38 was immersed in 696 nM NOS at time 0. Binding was measured for 300 s followed by transfer to
buffer only and monitoring of dissociation for 300 s. Trace a (circles), eNOS binding with an additional step in which the tip was moved into buffer with 1 lM CaM after initial
dissociation. Trace b (squares), nNOS binding. Trace c (triangles), eNOS pre-equilibrated with a fourfold molar excess of CaM prior to immersion of p38. Arrows indicate
movement of sensors from association to dissociation or dissociation to CaM-containing buffer. (B) Sensorgrams of eNOS concentration course. eNOS concentrations in nM
units were 696 (open diamonds), 232 (squares), 77 (triangles), 26 (circles) and 0 (black diamonds). Fits to a two-component sequential model are shown as solid lines.
Dissociation phases were similar to trace a in Fig. 1. Kinetics parameter sets for successive traces in order of decreasing eNOS were 0.1, 0.01, .006, .001; 0.03, 0.01, 0.0002,
0.001; 0.0008. 0.01, 0.006, 0.001; 0.0025, 0.01, 0.0002, 0.001 in sec-1 for k1, k2. k3, and k4.
C.A. Chrestensen et al. / FEBS Open Bio 2 (2012) 51–55 53closely match the binding of nNOS in Fig. 1B are obtained at con-
centrations more than an order of magnitude lower.
Rapid binding is ﬁrst order with respect to analyte (varied
during titration), and the simulations are pseudo-ﬁrst order with
respect to immobilized ligand. Because the analyte is present in
great excess, the observed binding kinetics are ﬁrst order (in
immobilized ligand) at each analyte concentration. At high eNOS
concentrations the rate of binding (k1) is much faster than the rate
of release (k2), hence the apparent rate constant kobsk1. The pseu-
do ﬁrst order reaction rate at 232 nM eNOS is 0.03 ± 003 s1, corre-
sponding to a diffusion-limited rate constant of 0.13 ± .01 
106 M1 s1. Kd for eNOS binding to p38 is k2/k1, approximately
80 ± 10 nM.
As shown in Fig. 2A, dissociation of eNOS from p38 is incom-
plete. This is not due to attainment of equilibrium in the rapid
binding phase, because so little eNOS is bound to the sensor that
full release would not produce a concentration in the dissociation
buffer consistent with observable binding. We interpret these re-
sults in terms of a sequential model in which the complex on the
sensor is converted to a slowly released form. This process, occur-
ring on the sensor over a time scale of several minutes, is unlikely
to be biologically signiﬁcant, but modeling it improves our under-
standing of the fast phase.
3.2. eNOS binds to ERK
Fig. 3A shows similar experiments demonstrating the binding of
eNOS, but not nNOS, to ERK-2. The concentration dependence of
eNOS binding to ERK-2 is shown in Fig. 3B. The concentration
dependence is similar to that of the binding of eNOS to p38. The
apparent Kd in the single component ﬁt shown is about twice that
measured for p38, but the data are consistent with Kd values as
small as 90 nM (140 ± 50 nM). A single kinetics component
produces suitable ﬁts for the initial 100 s of binding. Rapid binding
is ﬁrst order with respect to the analyte, and at each analyte
concentration the observed kinetics are pseudo ﬁrst order as in
Section 3.1. The pseudo ﬁrst order reaction rate at 100 nM eNOSis 0.125 ± 0.025 s1, corresponding to a diffusion-limited rate con-
stant of 0.125 ± 0.025  106 M1 s1. Low amplitude, likely due to
low binding activity of ligand, prevented accurate determination
of off rates. Steady state analysis (Fig. 3C) of the binding in
Fig. 3B yielded a Kd of 160 nM.
The effect of p38 binding on eNOS activity was investigated
using the cytochrome c reduction assay for electron transfer and
the hemoglobin capture assay for NO production. There was no sig-
niﬁcant effect on cytochrome c reduction. Weak inhibition of NO
formation by 1 lM p38 in the presence of 0.6 lM CaM was ob-
served; NO production was reduced by an average of 30%. This is
consistent with competition between p38 and CaM, assuming that
CaM is the stronger ligand as indicated in biosensor experiments.
The protein–protein interaction alone does not appear to signiﬁ-
cantly affect eNOS activity; experiments investigating phosphory-
lation events are in progress.
3.3. Discussion
We demonstrate that p38 and ERK-2 bind eNOS with high afﬁn-
ity and bind nNOS only weakly or not at all, supporting the hypoth-
esis that the pentabasic sequence in the autoinhibitory element of
eNOS, but not nNOS, is recognized by map kinases. Competition
with CaM provides additional support for the pentabasic sequence
as a MAP kinase target since these elements are proximally located
in the three dimensional structure [19]; displacement of the AI by
CaM is the primary activating event in both eNOS and nNOS.
The rapid binding and high afﬁnity observed suggest but do not
prove that the proteins associate physiologically. Afﬁnity of the
established physiologically relevant MK2B-p38 interaction is
6.4 nM [29], comparing well with eNOS-p38 afﬁnity. Physiological
p38-eNOS binding would have great potential in mediating
signaling pathways known to involve both eNOS and p38. Other ki-
nases might associate with the p38-eNOS complex rather than act
as free intermediates. Trafﬁcking of eNOS to cellular compartments
is established [16–18], providing opportunity for differential inter-
action with p38 in some cell states. Numerous papers have
Fig. 3. (A) Association phase of eNOS and nNOS binding to ERK-2. Immobilized
ERK2 was immersed in 200 nM NOS at time 0. Trace a (circles), eNOS binding. Trace
b (squares), nNOS binding. Solid lines indicate ﬁts to a single exponential. (B)
sensorgrams of eNOS concentration course. eNOS concentrations in nM units were
1.6 lM (yellow), 0.8 lM (green), 0.4 lM (orange), 0.2 lM (purple), 0.1 lM (blue),
25 nM (red) and 0 (brown). Solid lines indicate ﬁts to a single exponential. (C) plot
of steady state amplitude against eNOS concentration. The ﬁt shown is for
Kd = 160 nM.
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ulating both the expression and phosphorylation state of eNOS;
some of these pathways inhibit and others activate NO synthesis
(e.g., [30,31]) strongly suggesting a mixture of mechanisms that in-
clude pathway mediated effects and direct effects (e.g., direct
phosphorylation of eNOS by ERK or p38, or activation of an inter-
mediate activating kinase such as AKT in a multiprotein signaling
complex).
Available evidence demonstrates that ERK directly phosphory-
lates eNOS in BAECs, and forms complexes with eNOS and addi-
tional components [11]. These complexes are likely to be
mediated at least in part by the interactions studied here. We point
out that the location of the pentabasic motif, adjacent to the PKA
phosphorylation site S633, suggests a mechanism of interaction
between modes of inactivation and activation on the enzyme.
Recently we directly conﬁrmed inhibition of CaM binding after
PKC phosphorylated T495, adjacent to the tribasic motif directly
at the start of the CaM canonical target [20]. It is of interest that
the MAPK binding site is located in the AI adjacent to a comparable
phosphorylation site; the MAPK site exposure is increased by AI
displacement but MAPK competes with CaM, and the MAPK bind-
ing is positioned to interact with both PKA and AKT phosphoryla-
tion sites.An alternative possibility with broader implications would
involve additional partners. The pentabasic sequence of eNOS is
recognized by a binding partner in mitochondria [32]. Similar ele-
ments are involved in nuclear trafﬁcking. It is easy to envision a
system of alternating partners bearing base-rich sequences and
their recognition sites that would enable kinases activated by
MAP kinases to interact with partners and in turn, eNOS. Such
interactions could create a phosphorylation cascade, but could also
be the basis for inhibition. We are now investigating the potential
of eNOS-MAPK interactions for enhancement of eNOS phosphory-
lation and inhibition of MAPKAP-2/3 kinases.
3.4. Conclusions
The endothelial nitric oxide synthase binds MAP kinases at a
pentabasic site in the unconserved region of the autoinhibitory
insertion associated with the eNOS FMN binding domain. No po-
tential MAPK phosphorylation sites are associated with this region
in eNOS, but there are many good candidates elsewhere in the
eNOS structure that may be accessible to a kinase bound at the
pentabasic site. MAP kinases bind eNOS, but not homologs lacking
the pentabasic site, with 100 nM afﬁnity and a forward rate
constant of 1.3  105 M1 s1. Calmodulin forms a ternary com-
plex that weakly promotes dissociation of p38 from eNOS. The
eNOS-MAP kinase interaction may provide a scaffold for the forma-
tion of larger complexes with additional components, including
Akt and Raf-1.Acknowledgements
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